A Federal Court judge has put ASIC’s first fees for no service case, brought against two units of National Australia Bank’s wealth management division, on an expedited timetable, saying the case was not new territory for the bank.
A Federal Court judge that threw out a consumer class action against MyBudget has denied the budget management company’s bid for costs, finding the case was brought in the public interest.
A Federal Court judge has allowed the plaintiffs in a class action alleging a unit of Westpac failed to detect the fraud of convicted Ponzi schemer Michael Samra to proceed with their claims against Samra’s defunct company.
HarperCollins has lost its bid for summary dismissal of a defamation lawsuit brought against it by two psychiatrists at the centre of the deep sleep therapy scandal that rocked the medical world in the 1960s and 70s.
The stakes will be high for both sides when some of the country’s top competition lawyers face off against the ACCC Tuesday in the first hearing in a closely watched criminal cartel case against three investment banks over a $2.5 billion ANZ institutional share placement.
Australian food manufacturer Trident Foods has won a partial victory after facing two appeals from US seafood giant Trident Seafoods seeking to remove its trade marks.
An investor suing property investment group Aviation 3030 can’t avoid payment of half a million dollars in security for litigation costs because of a parallel enforcement action by the corporate regulator, a judge has ruled.
The Australian Patent Office has thrown out Fisher & Paykel Healthcare’s opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.
Shine Lawyers has acquired boutique class action firm ACA lawyers, a deal that will create the second largest class action firm in Australia by caseload and position the firm to take advantage of an expected increase in shareholder class action work.
Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.